U.S. markets closed

BioCardia, Inc. (BCDA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.9000+0.0600 (+1.24%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close4.8400
Open4.8000
Bid4.9000 x 1000
Ask4.9200 x 900
Day's Range4.7700 - 5.0000
52 Week Range1.9100 - 8.6000
Volume159,240
Avg. Volume103,089
Market Cap82.285M
Beta (5Y Monthly)1.95
PE Ratio (TTM)N/A
EPS (TTM)-1.0660
Earnings DateAug 11, 2021 - Aug 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.17
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Is BioCardia, Inc. (BCDA) A Good Stock To Buy?
    Insider Monkey

    Is BioCardia, Inc. (BCDA) A Good Stock To Buy?

    In this article you are going to find out whether hedge funds think BioCardia, Inc. (NASDAQ:BCDA) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among […]

  • BioCardia to Be Added to the Russell Microcap® Index
    GlobeNewswire

    BioCardia to Be Added to the Russell Microcap® Index

    SAN CARLOS, Calif., June 14, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular and pulmonary cell based therapies, today announced it is to join the Russell Microcap® Index. This milestone will take place at the conclusion of the 2021 Russell Indexes annual reconstitution, effective after the U.S. market opens on June 28, 2021, according to a preliminary list of additions posted June 4, 2021. “BioCardia’s inclusion

  • BioCardia to Present at the LD Micro Virtual Invitational Conference on June 8, 2021
    GlobeNewswire

    BioCardia to Present at the LD Micro Virtual Invitational Conference on June 8, 2021

    SAN CARLOS, Calif., June 02, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular and pulmonary cell based therapies, announced today that Chief Executive Officer Peter Altman will present a corporate overview at the three-day LD Micro Virtual Invitational Conference being held on June 8 – 10. Mr. Altman will deliver his corporate presentation on June 8 at 4:30pm ET, Track 3. Investors can register to watch the presen